This year, more than 13,000 Kansans will receive a cancer diagnosis. They will join more than 200,000 Kansas adults who are already living with the disease, including Micki Scherling of Goodland — a three-time breast cancer survivor.

A new facility, the Laboratory for Early Stage Translational Research (LESTR), recently opened on the University of Kansas – Lawrence campus and will be devoted entirely to the development of biochemical assays or cell-based assays with defined biochemical read-outs.

It sounds like science fiction: high-energy radiation therapy kills cancerous tumors of the lung, breast, head and neck, spine, liver and abdomen in record time. But at The University of Kansas Cancer Center, TrueBeam™ and GammaPod are not science fiction at all.

Building on four years of record private giving, KU Endowment has publicly launched Far Above: The Campaign for Kansas, a $1.2 billion fundraising campaign to support the aspirations of the University of Kansas and The University of Kansas Hospital.

Terance T. Tsue, MD, a distinguished Otolaryngology-Head and Neck Surgeon and researcher, has been named the first Physician-in-Chief for The University of Kansas Cancer Center. In this position, Dr. Tsue (pronounced sue-A) provides the clinical oversight at The University of Kansas Cancer Center, ranked 44th nationally among hospital cancer programs by U.S. News & World Report.